EUVIMEDEUVIMED entdecken
Crossref

Caspase-3/gasdermin-E axis facilitates the progression of coronary artery calcification by inducing the release of high mobility group box protein 1

Honghui Yang, Yingying Liu, Gengyu Chen, Botong Zhou, Guian Xu, Qingman Li, Lijie Zhu

International Immunopharmacology · 2024-01 · 127 · 111454

DOI: 10.1016/j.intimp.2023.111454 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024-01. Verfasst von Honghui Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Zhengzhou University, Central China Fuwai Hospital, Zhengzhou 451464, PR China. Electronic address: 19503809999@163.com. Hauptthemen laut MEDLINE: Coronary Artery Disease, HMGB1 Protein. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronary artery calcification (CAC) is commonly observed in atherosclerotic plaques, which is a pathogenic factor for severe coronary artery disease (CAD). The phenotype changes of vascular smooth muscle cells (VSMCs) are found to participate in CAC progression, which is mainly induced by vascular inflammation and oxidative stress (OS). HMGB1, a critical inflammatory cytokine, is recently reported to induce arterial calcification, which is regulated by the Caspase-3/gasdermin-E (GSDME) axis. However, the function of the Caspase-3/GSDME axis in CAC is unknown. Herein, the involvement of the Caspase-3/GSDME axis in CAC was studied to explore the possible targets for CAC. CAC model was constructed in mice, which was verified by red cytoplasm in coronary artery tissues, increased macrophage infiltration, aggravated inflammation, and enhanced RAGE signaling, accompanied by an increased release of HMGB1 and an activated Caspase-3/ GSDME axis. In β-GP-treated MOVAS-1 cells, calcification, the ROS accumulation, enhanced LDH and HMGB1 release, enlarged macrophage production, aggravated inflammation, and activated RAGE signaling were observed, which were markedly abolished by the transfection of si-HMGB1 and si-GSDME. Moreover, the calcification deposition, the activity of Caspase-3/ GSDME axis, release of HMGB1, macrophage infiltration, cytokine production, and RAGE signaling in CAC mice were notably alleviated by VSMCs-specific GSDME knockdown, not by hematopoietic stem cells (HSCs)-specific GSDME knockdown. Collectively, Caspase-3/GSDME axis facilitated the progression of CAC by inducing the release of HMGB1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseHMGB1 ProteinAnimalsMicePyroptosisGasderminsCaspase 3CytokinesInflammation

Stichwörter der Autor:innen

Caspase-3Coronary artery calcificationGSDMEHMGB1Pyroptosis

Substanzen

GasderminsCaspase 3HMGB1 ProteinCytokines

Autor:innen und Institutionen

  • Department of Cardiology, Zhengzhou University, Central China Fuwai Hospital, Zhengzhou 451464, PR China. Electronic address: 19503809999@163.com.
  • Department of Cardiology, Zhengzhou University, Central China Fuwai Hospital, Zhengzhou 451464, PR China.

Zitieren

APA

Yang, H., Liu, Y., Chen, G., Zhou, B., Xu, G., Li, Q., & Zhu, L. (2024). Caspase-3/gasdermin-E axis facilitates the progression of coronary artery calcification by inducing the release of high mobility group box protein 1. International Immunopharmacology, 127, 111454. https://doi.org/10.1016/j.intimp.2023.111454

Vancouver

Yang H, Liu Y, Chen G, Zhou B, Xu G, Li Q, et al. Caspase-3/gasdermin-E axis facilitates the progression of coronary artery calcification by inducing the release of high mobility group box protein 1. International Immunopharmacology. 2024;127:111454. doi:10.1016/j.intimp.2023.111454

BibTeX
@article{Yang2024,
  author = {Yang, Honghui and Liu, Yingying and Chen, Gengyu and Zhou, Botong and Xu, Guian and Li, Qingman and Zhu, Lijie},
  title = {Caspase-3/gasdermin-E axis facilitates the progression of coronary artery calcification by inducing the release of high mobility group box protein 1},
  journal = {International Immunopharmacology},
  year = {2024},
  volume = {127},
  pages = {111454},
  doi = {10.1016/j.intimp.2023.111454}
}
Kostenlos starten →